Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, 4-Period Crossover Study in Healthy Egyptian Male Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, 4-Period Crossover Study in Healthy Egyptian Male Volunteers

Published:2013-06 Issue:6 Volume:35 Page:846-861
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hedaya Mohsen A.,Helmy Sally A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference72 articles.

1. European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document;Mancia;J Hypertens,2009

2. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

3. ACCOMPLISH Investigators. Exceptional early blood pressure control rates: the ACCOMPLISH trial;Jamerson;Blood Press,2007

4. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients;Jamerson;N Engl J Med,2008

5. Angiotensin II receptors and angiotensin II receptor antagonists;Timmermans;Pharmacol Rev,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress;Journal of Inflammation Research;2024-04

2. Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework;The Journal of Clinical Pharmacology;2023-11

3. Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers;Clinical Therapeutics;2022-07

4. The Evaluation of Valsartan Biopharmaceutics Properties;Current Drug Research Reviews;2020-06-19

5. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K;American Journal of Physiology-Renal Physiology;2019-10-01